RICHARD D PETERSON
CIK 1430423 · Chief Financial Officer · last filed 2026-06-12
RICHARD D PETERSON is a Chief Financial Officer who has filed 47 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for UVE, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.1M across reported positions. 18 SEC filings were submitted jointly with UNIVERSAL INSURANCE HOLDINGS, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$17.14M
4
47
-$2.68M
Filer Profile
FORT LAUDERDALE, FL 33309
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UVE | Director | 28,869 | $44.33 | $1.28M | -$52.3K | 12 | 2026-06-12 |
| Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Chief Financial Officer | 55,800 | $0.01 | $759 | $0 | 1 | 2021-12-14 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Chief Financial Officer | 7,000 | — | — | $105.0K | 2 | 2017-08-01 |
| MRX | EVP, CFO & Corp Treasurer | 217,289 | $73.00 | $15.86M | -$2.73M | 29 | 2012-08-17 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | UVE | Grant (A) | +3,414 | $0 | EDGAR |
| 2026-03-30 | UVE | Notice (144) | −2,000 | -$67.3K | EDGAR |
| 2025-12-31 | UVE | Sell (S) | −1,855 | -$62.3K | EDGAR |
| 2025-12-30 | UVE | Notice (144) | −1,855 | -$63.3K | EDGAR |
| 2025-07-30 | UVE | Grant (A) | +2,824 | $0 | EDGAR |
| 2025-06-13 | UVE | Grant (A) | +2,404 | $0 | EDGAR |
| 2024-06-17 | UVE | Grant (A) | +3,491 | $65.0K | EDGAR |
| 2023-06-22 | UVE | Grant (A) | +4,005 | $0 | EDGAR |
| 2022-10-03 | UVE | Buy (P) | +1,075 | $10.0K | EDGAR |
| 2022-06-14 | UVE | Grant (A) | +5,337 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.